Smith BD, Brummendorf TH, Roboz GJ, Gambacorti-Passerini C, et al. Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study. Leuk Res 2024;139:107481.
PMID: 38484432